DRUG · COUNSELLING NOTES
Polatuzumab Vedotin
POLIVY
Updated
New prescription
indication: _____. IV infusion q3 weeks; report numbness/tingling; warned on allergies; serious/common AEs: neutropenia, neuropathy, infusion reactions, infection; non-pharm: hand hygiene, rest
Refill prescription
refilled, adherence discussed, no SEs were reported
Dose change
Dose change discussed. new dose reviewed; IV infusion q3 weeks; report numbness/tingling; warned on allergies; serious/common AEs: neutropenia, neuropathy, infusion reactions, infection; non-pharm: hand hygiene, rest